March 12, 2020, was at all times going to be memorable for Jason Feldman, as a result of that was the day his males’s health-focused startup, Vault Health, was set for a significant rebrand and nationwide rollout. But now the day is etched in his thoughts as a result of it set his firm on an sudden trajectory that led to development past his expectations.
On that mid-March Thursday, Feldman stood on the inventory market ground in New York and witnessed the chaos because the nation’s Dow Jones Industrial Average and S&P 500 noticed the best single-day share dip since 1987.
Subscribe to the Crunchbase Daily
The founder and CEO was there to pose for pictures and supply an interview to announce Vault Health’s subsequent strikes, however as an alternative discovered the market was reacting to the COVID-19 virus. The lethal coronavirus had been declared a pandemic by the World Health Organization the day earlier than, and could be branded a nationwide emergency within the United States by then-President Donald Trump lower than 24 hours later.
“I was there watching these investors on the floor of the stock exchange freaking out because the market literally was crashing,” Feldman remembered in a latest interview with Crunchbase News. “So we go back to the office, and I thought ‘What are we going to do?’ Because we had literally just launched the brand nine months before and built all this technology and here we are. Now I’m afraid that peoples’ jobs are at risk, and I don’t know how we’re going to live.”
Vault not solely lived, however grew considerably over the following 12 months and a half.
The pandemic set in movement a brand new trajectory for a lot of healthtech startups, significantly these nimble sufficient to answer a world disaster that confused and broke conventional public well being care programs. And whereas tech’s contribution in the course of the pandemic was a blended bag of fine and dangerous, people who discovered methods to shortly fill the wants of scared residents, governments and firms have been rewarded.
Investors within the house raced to place cash into digital well being startups final 12 months. In all, the business raised $16.6 billion in investments globally whereas the pandemic raged on, up from $12.5 billion the 12 months earlier than, based on Crunchbase information. So far in 2021, the business has raised almost $20 billion in funding, the information present.
Of people who efficiently made a pandemic pivot, many lucked out having present partnerships with key diagnostics labs, automated programs that slotted into well being care programs simply, or had a longtime digital-first mannequin for sufferers hoping to keep away from leaving the home.
But interviews with three of these startups—Vault Health, genetic testing firm Color, and Nurx, which carved its path early on because the go-to for at-home reproductive well being care—reveal that these making the pivot from their authentic focus to COVID-19 additionally made a few of their very own luck by way of key investments and adjustments they hope will increase American well being care ceaselessly.
Now these startups—and others like them—are poised to be busier than ever as corporations and authorities companies put together to adjust to the Biden administration’s vaccine or check mandate for corporations with greater than 100 workers returning to the workplace.
Here’s how they did it.
Vault: A fast pivot to COVID testing
Feldman admits he briefly puzzled if he ought to pause the nationwide rollout in hopes the pandemic would move in weeks or months. Instead, he made a tough flip towards testing for the novel coronavirus when he realized one of many firm’s companions, Rutgers University, was engaged on a saliva check for COVID-19. Felman proposed partnering to get the assessments to folks.
“They said ‘That’s not possible, you can’t do at-home testing because the FDA stopped all at-home testing,’” he mentioned. “We showed them how we could actually create a visit where you’d have a practitioner [online] watching somebody spit in a tube at home and then we got UPS to say that they would help us deliver really fast, so we did all of that.”
By mid-April 2020, Rutgers had produced an FDA-approved saliva check for COVID-19 and Vault was working to get it to folks. The firm began partnering with authorities companies in search of course in amassing the samples, working them by way of a lab, and managing the outcomes. Already it’s fielding requests for its office coronavirus administration packages to trace who has been vaccinated and to handle digital, mail-in testing.
Vault Health additionally targeted on diversifying its personal suppliers—a transfer that might develop into more and more essential because the pandemic continues to sluggish delivery and the broader provide chain.
When Vault Health confirmed as much as the inventory market ground to roll out its providers nationally, it had about 43 workers with a headquarters in New York, and about $10 million within the financial institution from a Series A fundraising spherical.
Today, it’s grown to greater than 500 staff who stay everywhere in the nation and has one other 100 openings, that are anticipated to be crammed subsequent 12 months.
Color: Rallying to a pandemic response
Color was an organization that, it seems, was unwittingly poised for a pandemic.
Its mission, although initially targeted on genetics, was about assembly folks the place they have been to get medical providers, together with just about the place doable. It ran a clinical-grade, extremely automated laboratory and had the know-how to arrange medical providers and get folks their check outcomes shortly.
When Bay Area well being officers introduced the earliest shelter-in-place order within the nation on March 16, Caroline Savello, Color’s chief industrial officer, was optimistic the disaster would final six weeks to a few months at most.
Still, within the days earlier than the area all however shuttered, she and a few of her colleagues sat on a name discussing how Color might assist with the pandemic response.
“This was in some of these early days of testing when people literally weren’t getting their test results for weeks because you had to have a nurse call you … and there was no way that was going to scale up,” she mentioned. “Everything was completely incumbent on these already very overtaxed health care settings. … So we were saying, ‘Is there just a way to offload this completely from the traditional health care system and make it so that this can be accessible?’”
The metropolis of San Francisco was one in every of Color’s earliest shoppers, utilizing the corporate’s programs to assist handle scheduling, prepare folks to gather samples, and streamline the lab and outcomes course of. Today, the corporate works with greater than 150 U.S. employers to handle COVID vaccine standing and testing protocols, together with for a lot of of its personal lab staff who don’t have the choice of working from house.
What units Color aside is its funding in automation and robotics that may assist get jobs achieved and it’s deal with creating programs and processes that may be simply replicated and scaled, Savello mentioned. It’s providers are supposed to be tremendous scalable.
“Everything is out of the box: You have the signage, you have the kits, you have the ship-back materials—that’s exactly how we think about employers,” Savello mentioned. “Literally, you could pop up a testing program out of a box, and have somebody from your employee health and safety group set up the tests, set up the table once a day, and pack it up at night.”
Color has grown from about 140 workers at first of the pandemic to about 600 staff immediately, and has partnerships with eight laboratory companions throughout the nation.
Nurx: From contraception to COVID assessments
Nurx, the telehealth startup that made its title because the place to discreetly get contraception, STD assessments and different reproductive well being care from house, made COVID testing one in every of its verticals in April this 12 months after the FDA started approving at-home assessments and the U.S. authorities started investing in making the know-how extra obtainable.
The first batch of assessments Nurx ordered have been passed by mid-summer, as coronavirus instances started to rise. Most of the availability was wolfed up not by the people who historically make up the majority of Nurx’s prospects, however by companies returning to the workplace, film manufacturing websites, summer season camps and people internet hosting massive occasions, Nurx Chief Medical Officer Dr. Jennifer Peña informed Crunchbase News.
“When we decided to launch this, that demand [for tests] kind of had gone down because we were trying to get over this pandemic, people were getting vaccinated,” Peña mentioned. “But now, of course, the Delta variant and others came about, the resistance to vaccination is still an issue and … people want to get out and travel, enjoy the summer.”
Nurx is ready on its subsequent batch of COVID assessments to reach by the tip of October and is making ready for a lot greater, ongoing demand as the belief units in that the pandemic remains to be removed from over and common testing might develop into a lifestyle for many individuals.
But if that’s the case, Peña mentioned, it needs to be extra handy for sufferers. That’s significantly essential for these working for an hourly wage on the entrance strains of America’s companies, who might not have the assets or time to make a health care provider’s appointment or a particular journey for well being care—not just for COVID, however for a lot of illnesses.
“We already had telemedicine before the pandemic,” she mentioned. “Obviously the pandemic has been tragic, but it really has highlighted the importance of telemedicine and there’s no going back.”
Illustration: Dom Guzman
Stay updated with latest funding rounds, acquisitions, and extra with the